Measurement of the branching ratios for 6P 1/2 decays to 6S 1/2 and 5D 3/2 in 138 Ba + are reported with the decay probability from 6P 1/2 to 5D 3/2 measured to be p = 0.268177 ± (37)stat − (20)sys. This result differs from a recent report by 12σ. A detailed account of systematics is given and the likely source of the discrepancy is identified. The new value of the branching ratio is combined with a previous experimental results to give a new estimate of τ = 7.855(10) ns for the 6P 1/2 lifetime. In addition, ratios of matrix elements calculated from theory are combined with experimental results to provide improved theoretical estimates of the 6P 3/2 lifetime and the associated matrix elements. arXiv:1905.06523v1 [physics.atom-ph]
The uniformity of the intensity and phase of laser beams is crucial to high-performance atom interferometers. Inhomogeneities in the laser intensity profile cause contrast reductions and systematic effects in interferometers operated with atom sources at micro-Kelvin temperatures, and detrimental diffraction phase shifts in interferometers using large momentum transfer beam splitters. We report on the implementation of a socalled top-hat laser beam in a long-interrogation-time cold-atom interferometer to overcome the issue of the inhomogeneous laser intensity encountered when using Gaussian laser beams. We characterize the intensity and relative phase profiles of the top-hat beam and demonstrate its gain in atom-optics efficiency over a Gaussian beam, in agreement with numerical simulations. We discuss the application of top-hat beams to improve the performance of different architectures of atom interferometers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.